MTOR and neoplasm: In mouse tumor models, M2 TAMs have been shown to preferentially express soluble GPNMB which combines with the CD44 receptor on tumor cells and promotes CSC proliferation via PI3K/AKT/mTOR or β-catenin/MAPKs/AMPK/Src signaling [223].